Navigation Links
US grant exclusive for UK dementia researcher
Date:11/9/2011

The US-based Alzheimer's Association has awarded Dr. David Llewellyn of Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, a prestigious two-year $100,000 New Investigator Research Grant to further his dementia research. New Investigator awards are made following international peer review among applicants who are the most promising researchers who have earned their doctoral degrees within the last 10 years.

Dr. Llewellyn is the only researcher in the UK to receive an award from the Alzheimer's Association in 2011.

Dr. Llewellyn's goal is to investigate how low vitamin D levels may increase the risk of dementia and neuroimaging abnormalities, such as brain shrinkage in the US Cardiovascular Health Study. Named collaborators on this international project are Professor David Melzer (PCMD), Professor Kenneth Langa (University of Michigan), Dr Paulo Chaves (Johns Hopkins University) and Dr Bryan Kestenbaum (University of Washington). Support from the Alzheimer's Association will provide funding for a post-doctoral researcher to join Dr. Llewellyn to investigate vitamin D's potential as a biomarker and therapeutic target.

"It is an honour to receive this Alzheimer's Association award not only for myself but also for the wider Epidemiology and Public Health group at PCMD and our transatlantic collaborators," Dr. Llewellyn said. "Support from the Alzheimer's Association and other funders is vital to accelerate the pace of discovery that we are able to achieve and lay the foundations for our future research programme."

He added: "Unfortunately, the underlying causes of dementia are still largely unknown and current options for prevention and treatment are limited. However, the high proportion of vitamin D deficiency seen in people with cognitive impairment and dementia may provide us with an important clue. Few foods contain vitamin D, synthesis from sunlight is not possible for much of the year at northern latitudes, and skin becomes less efficient at producing vitamin D with age. Given the coming dementia epidemic, we need to investigate new therapeutic strategies such as vitamin D supplementation as a matter of urgency.".

In 2011, the Alzheimer's Association's International Research Grant Program awarded more than $12.8 million in funding to 78 investigators. Funded projects represent the proposals ranked highest by peer reviewers in an extremely competitive field of 875 applications.

"The Alzheimer's Association is pleased that, through this research grant, Dr. Llewellyn and his team will continue their innovative research, and we look forward to seeing his advances in the fight against Alzheimer's disease," said Maria Carrillo, Ph.D., senior director of medical and scientific relations at the Alzheimer's Association.

Dr. Llewellyn and his collaborators published the first study to identify a link between low vitamin D levels and the onset of new cognitive problems last year in the leading journal Archives of Internal Medicine, which attracted widespread international media attention. Dr. Llewellyn's research is also supported by the UK National Institute for Health Research Peninsula Collaboration for Leadership in Applied Health Research and Care (PenCLAHRC) and grants from the James Tudor Foundation, the Norman Family Charitable Trust, the Peninsula College of Medicine and Dentistry Foundation, the Age Related Diseases and Health Trust, and the Sir Halley Stewart Trust.

Over 800,000 people in the UK now have dementia and this costs the UK economy 23 billion per year more than cancer (12 billion per year) and heart disease (8 billion per year) combined. The average cost for each person with dementia, 27,647, is greater than the average UK salary. As the population ages the number of people with dementia in the UK will double over the next 30 years, with costs likely to rise to over 50 billion a year. The global burden of dementia is also staggering and more than 115 million people across the globe will suffer from dementia by 2050.


'/>"/>
Contact: Andrew Gould
andrew.gould@pcmd.ac.uk
44-139-268-6107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Related medicine news :

1. Scripps Research scientist receives $1 million research grant from Novo Nordisk
2. Kessler Foundation scientists awarded grants to study cognition in MS
3. Survey finds that AIDS remains an unspeakable subject for African immigrants
4. Grant will help bridge digital divide for people with disabilities
5. Scott & White Cancer Research Institute receives $3.5 million grant
6. NYUCD awarded $2.2 million NIH grant to decode genome of caries-causing bacteria
7. BUSM researcher awarded 2 NIH grants totaling over $11 million
8. NYUCN receives $994,000 HRSA grant to research increasing nursing faculty diversity
9. Life in U.S. Not Always a Plus for Immigrants Health
10. Immigrants -- Swedens new poor pensioners
11. NYUCN receives $4.2 million NIH/NIDA grant to study injecting drug users in Kenya
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... 2017  CVS Pharmacy, the retail division of ... store design to enhance the retail customer experience ... products and expanded beauty selections paired with informational ... new offerings. Together with its innovative digital programs, ... customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology: